Logotype for Dun & Bradstreet Holdings Inc

Dun & Bradstreet (DNB) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Dun & Bradstreet Holdings Inc

Q4 2024 earnings summary

8 Jul, 2026

Executive summary

  • Achieved 3% organic revenue growth and expanded EBITDA margins by 30 basis points for full year 2024.

  • Q4 2024 revenue was $631.9 million, up 0.2% year-over-year; full year revenue reached $2,381.7 million, up 2.9% year-over-year.

  • Net income for Q4 2024 was $7.8 million; full year net loss narrowed to $(28.6) million from $(47.0) million in 2023.

  • Completed major technology and client migrations, positioning for future growth.

  • Ongoing strategic review process expected to conclude in Q1 2025, with potential outcomes including sale or divestitures.

Financial highlights

  • Q4 adjusted EBITDA: $260.0 million (41.2% margin); full year adjusted EBITDA: $926.6 million (38.9% margin, up 30 bps YoY).

  • Adjusted net income for 2024: $429.1 million ($0.98 EPS), nearly flat YoY.

  • Q4 net income: $7.8 million ($0.02 EPS), up from $1.7 million prior year.

  • Full year net loss: $28.6 million ($0.07 loss per share), improved from $47.0 million loss prior year.

  • Operating cash flow for the year was $436.9 million.

Outlook and guidance

  • 2025 revenue guidance: $2,440–$2,500 million (2.5%–5% growth); organic constant currency growth expected at 3%–5%.

  • Adjusted EBITDA expected at $955–$985 million; adjusted EPS $1.01–$1.07.

  • Net leverage targeted to improve to 3.25x by year-end 2025.

  • Q1 2025 expected at low end of guidance range due to ongoing process; growth to accelerate through the year.

  • Guidance based on adjusted interest expense of ~$200 million, D&A of $160–$170 million, tax rate of 22–23%, and capex of $190–$200 million.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Dun & Bradstreet